Tissue damage caused by virus infection is generally thought to be mediated in one of two ways: by cytocidal action resulting directly from the processes of viral replication or, indirectly, from the immune response of the host directed against "foreign" antigens. In the majority of cases, the immune response against infecting virus is likely to be beneficial, leading to the elimination of virus and virus-infected tissue. When, however, this tissue has a low turnover rate and/or is critical for the functional integrity of the organism, the immune response of the host may provoke the actual clinical and pathological manifestations of the disease.
In the study of immunospecific cytotoxicity and its possible role in multiple sclerosis, a demyelinating disease of the central nervous system (CNS) of man, parainfluenza viruses are of special interest. In general, they are readily capable of producing persistent or carrier infections, both in vitro and in vivo (12, 26, 33) , and are therefore suspected of being involved in the etiology of some of the chronic pathological manifestations known commonly as the slow virus diseases (37) . In particular, 6 /94, the strain of parainfluenza type 1 virus central to our current study, was originally isolated from cell cultures obtained by lysolecithin-mediated fusion of human multiple sclerosis brain cells with CV-1 cells (32) and has been characterized as a temperature-sensitive, phenotypic variant of Sendai virus (18) . Although the role of 6/94 virus in the etiology of multiple sclerosis is still uncertain, its origins and properties may indicate that 6/94 virus is the product of a persistent infection of human brain in vivo by a Sendai-like parainfluenza type 1 virus.
The ability of parainfluenza type 1 virus to initiate chronic pathological changes in CNS tissue was the subject of a series of recent reports in which it has been shown that intracerebral (i.c.) injection of either live or ultravioletinactivated 6/94 virus into adult mice produces an inflammatory reaction followed by preferential chronic degeneration of white matter (14; I. Zgorniak-Nowosielska, Y. Iwasaki, T. Tachovsky, R. Tanaka, and H. Koprowski, Arch. Neurol., in press). A similar injection into athymic (nude) mice, however, produced no such lesions (13) unless the nude mice were given a thymic graft. These results suggested that the pathological CNS changes after parainfluenza type 1 virus injection were thymus dependent. The question remained whether the pathology exhibited in these mouse brains was mediated by thymus-derived lymphocytes (T cells). That cytotoxic T cells directed against viral antigens may play a key role in damage to virus-infected cells is well documented (3, 5, 22, 29, 30) .
With these considerations in mind, we set out to determine the capacity of mice to produce cytotoxic T cells in response to parainfluenza type 1 virus and the optimum requirements for such immune cytotoxicity. The significance of these data and their possible implications to the pathogenesis of parainfluenza type 1 virus in-T-CELL KILLING OF 6/94 VIRUS-INFECTED CELLS fections are discussed.
MATERIALS AND METHODS
Virus growth and purification. 6/94 virus was propagated in specific pathogen-free, 8-day-old embryonated chicken eggs (SPAFAS, Inc., Norwich, Conn.) maintained at 33 C, concentrated, and purified as previously described (20) . The purity of the virus concentrate was determined by polyacrylamide gel electrophoretic analyses. The ratio of particle number (determined by electron microscopy) to protein concentration (determined by the Lowry procedure 1211) was determined (2 x 10" particles _ 0.1 jig of viral protein), and purified virus was aliquoted as a stock solution containing 1.0 mg of protein per ml of saline and stored in the cold (4 C).
Mouse strains. BALB/c (H-2"') and BALB/c athymic (nude) mice were bred at The Wistar Institute. Germfree BALB/c mice were kindly provided through Ulrike Lichti, National Institutes of Health.
Cell cultures. P815Y mastocytoma cells of DBA/ 2J (H-2") origin (6) and EL4 lymphoma cells of C57BL/6 (H-2h) origin (9) Immunization. Cells, 20 x 106 (P815Y, EL4, or CER) in 5 ml of RPMI medium, were infected with allantoic fluid containing 10 -5 egg-infectious doses of 6/94 virus for 60 min at 37 C. Infected cells were washed three times in phosphate-buffered saline (PBS) and reincubated in RPMI 1640 medium containing mitomycin C (50 ;Lg/ml) for 30 min at 37 C.
After washing, 5 x 10" cells in 0.2 ml of PBS were injected intraperitoneally (i.p.) per adult mouse (>10 weeks old). Mitomycin C treatment was necessary to prevent P815Y replication and formation of an ascitic tumor in BALB/c and DBA/2J recipients. When cell-free virus was the immunogen, purified 6/94 virus stock was diluted in PBS and inoculated i.p. or i.c.
Preparation of target cells and immune spleen cells. Cell cultures, immediately after infection (as noted above), were washed with PBS and adjusted to a density of 5 x 106 cells/ml in RPMI medium containing Na2CrO4 (New England Nuclear Corp.; 10 mCi/ml) at 200 ;LCi per 5 x 106 cells per ml. After incubation for 90 min at 37 C, the cells were washed three times with 10-ml volumes of medium. The efficiency of labeling was generally between 0.1 and 0.5 counts/min per cell. After incubation for 5 min at room temperature in PBS containing 5% FCS and 0.075% (wt/vol) erythrosin B (Allied Chemical, New York), cell viability was determined with a hemocytometer. Viability after infection and 5'Cr labeling was greater than 90%.
Spleen cells were prepared from immunized (and from control nonimmunized) mice as described previously (34).
Cytotoxicity assay. The procedure used is a modification of that outlined by Thorn et al. (34) . Replicate 0.1-ml aliquots of target cells containing 1.5 x 104 cells were added to the wells of microtest plates (LINBRO, New Haven, Conn.). Replicate wells then received 0.1 ml of spleen cells to give spleen cell-totarget cell ratios as noted in the text. After incubation at 37 C for selected intervals, replicate plates were centrifuged and 0.1 ml of supernatant was removed and counted in a gamma scintillation spectrophotometer to measure the amount of 5"Cr released from target cells.
Calculations Treatment of spleen cells with antiserum and complement. Aliquots containing 2 x 107 viable spleen cells were centrifuged and the pellets were suspended in 2.0 ml of a 1:5 dilution in RPMI of normal mouse serum (ICR), AKR anti-C3H thymus (anti-@) serum, and unadsorbed rabbit anti-mouse F(ab')2. The samples were incubated for 30 min at 0 C and centrifuged, and the pellets were suspended in 4 ml of a 1:20 dilution of guinea pig serum in RPMI medium. After cell number and viability were determined, the cells were diluted to the volume necessary to give a 150:1 ratio in the assay (assuming no loss of cells during treatment).
RIA. Blood samples were taken from the tail vein, and the blood clot was allowed to retract overnight at 4 C. The sera, freed of cells by centrifugation, were stored at -20 C and were used without prior inactivation. Antiviral antibody present in the sera was quantitated using a radioimmunoassay (RIA) described in detail elsewhere (W. Gerhard, T. J. Braciale, and N. R. Klinman, Eur. J. Immunol., in press).
Determination of virus replication in target cells. Cells were infected as noted above and aliquots of 5 x 10" cells were incubated either in standard RPMI medium or in medium 199, which was 90% deficient in amino acids and contained a :H-labeled amino acid mixture (50 ,uCi/ml) (New England Nuclear Corp., Boston). The cell-free culture fluids obtained after consecutive 6-h labeling periods were monitored for the release of labeled virus by pelleting in the presence of unlabeled purified carrier virus; the resulting pellet was resuspended and analyzed by sedimentation through a 25 to 55% gradient of sucrose.
Immune precipitation of cell-associated viral protein was performed by a slight modification of a method described in detail elsewhere (19) . Nonidet P-40 lysates of washed cells, after removal of nuclei and unsolubilized debris, were incubated for 1 h at 37 C with an excess of antiviral antibody (10 Al of hyperimmune rabbit anti-6/94 serum prepared against purified virus). Indirect immune precipitation was effected with 100 ,l of goat anti-rabbit gamma globulin serum (19) . Solubilization and sodium dodecyl sulfate-polyacrylamide gel electrophoresis of both supernatant virus (p = 1.20 -1.23 from a sucrose gradient) and immune precipitates were performed as previously described (11), except that the Laemlii-type gel system was 7.5% in acrylamide.
RESULTS
Kinetics of the cytotoxic response to viral determinants. Previous studies (M. Gorny, personal communication) showed that P815Y infected with 6/94 virus was susceptible to complement-dependent lysis with anti-6/94 virus antibody. This demonstrated the expression of viral antigen on the cell surface and suggested the suitability of these cells as targets for lysis mediated by virus immune cells.
To determine the kinetics of response to parainfluenza type 1 viral antigens, both virus-infected and normal P815Y mastocytoma cells were labeled with 'Cr and mixed with spleen cells prepared from BALB/c mice at 3, 5, 7, and 10 days postimmunization with 6/94 virus-infected P815Y cells, hereafter also termed P815Y (6/94 ). An effector cell-to-target cell ratio of 150:1 was chosen, and 5Cr release was measured after 6 and 18 h. Figure 1 shows that maximum activity occurred at, or close to, day 5, and was negligible by day 10. These kinetics are similar to those seen in previous studies using lymphocytic choriomeningitis (LCM) virus (5), ectromelia virus (7), or vaccinia virus (17) . Percentage of specific lysis increases with time of incubation, but beyond 18 h the accuracy of the assay decreased due to the accumulated spontaneous 5Cr release (-2% per h).
The specificity of the reaction for virus-infected cells is shown by the failure of spleen cells from animals sensitized with P815Y (6/94) to lyse uninfected P815Y. Attempts were made to use P815Y targets infected with other budding viruses, measles, and an Ao influenza virus strain as specificity controls in the assay. However, since P815Y infected with these viruses did not induce cytotoxic cells against the homologous targets, the failure of cytotoxic cells induced with P815Y (6/94) to kill targets infected with measles or influenza is inconclusive and these data are not shown.
Kinetics of the cytotoxic response to uninfected allogeneic cells. The above kinetics of appearance of cytotoxic effector cells to 6/94 viral antigens is more rapid than that reported for the in vivo response in mice to immuniza- tion with allogeneic histocompatibility antigens, where maximum cytotoxic activity is observed in the spleen cells at 10 to 12 days after i.p. immunization (2) . To verify that the early appearance of cell-mediated cytotoxicity to viral antigens is not an artifact of our model system, BALB/c mice were immunized with 5 x 10 mitomycin-treated EL4 cells and their spleen cells were assayed for cytotoxicity against noninfected EL4 cells. Table 1 shows the results expressed in percentage of specific lysis for a spleen cell-to-target cell ratio of 150:1 performed 5 and 10 days after immunization. No significant cytotoxic activity was measurable on day 5; by day 10, however, spleen cells exhibited a low but significant cytotoxicity against allogeneic cells. These same spleen populations caused no lysis of P815Y or P815Y (6/94) target cells in the same assay. Thus the kinetics of appearance of cytotoxic cells in mouse spleen is more rapid upon exposure to viral antigens, presumably surface viral glycoproteins, than to histocompatibility antigens.
Correlation between viral polypeptide synthesis in target cells and their susceptibility to cell-mediated lysis. It was next of interest to ask whether the concentration of target antigen on the surface of the target cell played a major role in the incubation time required for maximum 5tCr release. We therefore compared as target cells P815Y that had been infected with 6/94 virus by our standard procedure (immediately prior to 'Cr labeling and mixing with spleen cells) with those that had been infected 20 h before the initiation of the cytotoxicity assay. Determination of the optimum spleen-totarget cell ratios and the requirement for H-2 compatibility between the spleen cells and the virus-infected target cells. Using spleens obtained from BALB/c mice immunized with 6/94 virus-infected P815Y and 6/94 virus-infected CER hamster cells, we examined the effect of increasing spleen-to-target cell ratios in the cytotoxicity test. Figure 3a shows that the percentage of specific lysis of P815Y (6/94) target cells increases approximately linearly with increasing amounts of spleen cells from both groups of mice. Though not shown, subsequent experiments indicated that specific lysis dropped appreciably above the ratio of spleen to target cells of 200:1.
Despite the fact that CER (6/94) and P815Y (6/94) cells are almost equally effective in stimulating killer spleen cells in BALB/c mice against the infected, H-2 compatible target cell, P815Y, no cytotoxic activity could be demonstrated against the infected xenogeneic cell line, CER (Fig. 3b) Figure 3c shows that although each of the infected cell lines was capable of stimulating virus-specific effector cells in BALB/c, efficient cytotoxicity occurred only when the 6/94-infected target cells were of the same H-2 type as that of the effector cells.
T-cell nature of the effector cells. To determine whether the observed cytotoxic activity was due to T cells, spleen cells obtained from BALB/c mice immunized with P815Y (6/94) were treated before the cytotoxicity assay with anti-0 antiserum plus complement. Table 3 shows that such treatment caused a marked reduction in cytotoxic activity, whereas rabbit anti-mouse F(ab'), caused little or no loss of activity. Moreover, in a separate experiment, little cytotoxic activity could be demonstrated in spleens of nude mice when stimulated identically to normal controls (Table 4 ). Taken together, these two results indicate that the observed cytotoxic response to 6/94 viral antigen is mediated mostly by T cells.
Comparison of virus-infected cells and purified virus as immunogens. In the same experiment (Table 4) (Table 5 ). The specificity of these antibodies for antigens of the 6/94 virus is substantiated by the failure of the same sera A/Melbourne/35 (HON1). Percent specific lysis refers to the results of a "'Cr release assay using spleen cells taken 5 days after i.p. immunization with P815Y (6/94), at a viable spleen cell-to-target cell (P815Y [6/94] to react in the same assay with an egg-grown influenza virus. In addition, since the antibodies belonged almost exclusively to the immunoglobulin G class and were not detectable in the immunoglobulin M class, these findings strongly suggest a previous exposure of most of our test animals to an agent antigenically related to 6/94, most probably Sendai virus. It has been claimed recently (1) that after secondary antigenic stimulation, memory T cells may give rise to an accelerated and more pronounced cell-mediated response. To evaluate the possible implications of previous exposure on the cell-mediated antiviral response, two groups of mice (with and without preexisting anti-6/94 serum antibody) were compared for their response to P815Y (6/94) cells (Table 5 and Fig. 4 ). In mice with preexisting anti-6/94 virus serum antibody (Fig. 4, open triangles) , the humoral antiviral response was detected earlier, and the level of antibody present by day 10 was higher, than in mice without preexisting antibody (closed triangles). In terms of the cell-mediated response (circles), although both groups of mice had higher cytotoxic activity on day 5 post-sensitization than on day 10, the group with preexisting 6/94 antibody (open circles) generated a significantly higher level of activity.
Histopathological survey. In the present study we examined a small number of mice to survey the histopathological changes in various tissues after i.p. inoculation of P815Y (6/94) and i.p. or i.c. inoculation of purified 6/94 virus. The major lesion, which occurred coincidentally with the peak of cytotoxic T-cell activity 5 days post-sensitization i.p. with P815Y (6/94), consisted of focal myocardial and epicardial necrosis with deposition of basophilic debris. With purified virus as immunogen administered i.p., the major histological lesion was serositis involving both pleural and peritoneal cavities. Brain lesions, however, were never detectable with either immunogen given by the i.p. route, even as late as 4 weeks after inoculation. In addition, we have observed that i.c. inoculation of 5 ,ug of purified 6/94 virus in BALB/c mice, which 4 months earlier had been immunized with the same dose of virus by the i.p. route, resulted in leptomeningeal mononuclear cell infiltration by day 5 and degenerative white matter lesions (by day 17) as previously reported by Iwasaki et al. (15) . No CNS lesions, however, were produced by the i.c. injection of PBS in combination with the i.p. injection of P815Y (6/94) in animals previously sensitized by the i.p. route, as might be expected if mechanical damage of brain tissue coincident with induction of cytotoxic T cells was sufficient for the appearance of such CNS lesions. A detailed presentation of these histopathological changes will be presented elsewhere.
DISCUSSION
In the present study we have investigated the induction of cytotoxic spleen cells after immunization of mice with parainfluenza type 1 virus or virus-infected cells H-2 identical, or allogeneic, or xenogeneic with the responder. The cytotoxic activity was analyzed in vitro using 51Cr release as a measure of lysis of virus-infected target cells. Cytotoxicity is specific for the viral antigens since (i) spleen cells from mice immunized with the allogeneic cell line EL4 have no effect on parainfluenza-infected P815Y target cells, (ii) uninfected target cells are not destroyed by spleen cells sensitized against virus, and (iii) infected target cells are not destroyed by normal spleen cells (from nonimmunized animals). Although specificity is dictated by the cell-bound viral antigens, efficient recognition and/or destruction of virusinfected target cells is apparently dependent, as previously described for other viruses (2, 4, 8) , on spleen cells with anti-F(ab'), serum and complement to eliminate B cells, followed by washing of the surviving cells to eliminate free antibody, did not significantly reduce cytotoxicity. These procedures also rule out a major contribution to the cytotoxicity measured in our present assay by antibody-dependent "null" lymphoid cells (10) . The induction of cytotoxic T cells by immunization with parainfluenza type 1 virus results in maximum cytotoxicity at about day 5 post-immunization, compared to day 10 when histocompatibility antigens are the immunogen. Our results with anti-6/94 virus antibody-free animals would suggest that this difference in kinetics is not related to the primary or secondary nature of the induction. It is reasonable to assume that the effector cells measured in this assay system in vitro correspond to the actual cytotoxic effector cells active in vivo. Moreover, it seems to follow from our studies in vitro that the degree and manifestations of the cell-mediated activity in vivo will depend not only on the concentration and localization of target structures but also on the actual number of effector cells reaching these target organs. For example, Mims and Blanden (24) have shown that i.c. inoculation of LCM virus together with LCM-reactive lymphocytes leads to an accelerated LCM disease. In addition, Johnson and Cole (16) have interpreted the induction of CNS disease in LCM carrier mice with virus-reactive memory T cells as being due to their greater potential for proliferation and generation of cytotoxic effector cells at the site of target structures. Thus, the finding of an enhanced cytotoxic response in virusprimed animals could explain the observation of Iwasaki et al. (13) , who showed that a suboptimal dose of 6/94 virus injected i.c. into mice would not of itself induce the development of the chronic thymus-dependent brain lesions but primed the animal for the induction of lesions following the i.c. injection of a second identical "suboptimal" virus dose 5 weeks later.
Previous studies on the pathogenesis of parainfluenza type 1 virus injection in mice have shown that different routes of inoculation result in distinctive patterns of pathology (15, 23, 28, 31) . The present histopathological results, in conjunction with the cytotoxicity data, suggest moreover that characteristic lesions can result from immune attack directed against viral antigens that localize in different tissues, depending upon the route of inoculation.
The major role that T cells play in the pathogenesis of a viral disease is well exemplified by recent data of Woodruff and Woodruff (36) , who observed that in the pathogenesis of coxsackievirus B: heart disease, T-cell-dependent reactions strongly influenced the extent of myocardial inflammation and necrosis. The exact mechanism by which a T-cell-mediated immune response to virus infection results in destruction of specific tissues remains undefined, although several possibilities present themselves. Pathology might result directly from a T-cell-mediated destruction of cells expressing viral antigen. Alternatively, T-cell-mediated destruction of tissue containing viral antigens might trigger a nonspecific localized inflammatory response as exemplified by the perivascular infiltration of mononuclear cells at the site of delayed hypersensitivity and homograft rejection; it is of particular interest that primary demyelination, characterized by segmental myelin damage without primary changes in the axon, has recently been shown to occur as a nonspecific consequence of such a delayed type of hypersensitivity reaction directed specifically against non-nervous tissue antigens (35) . Finally, virus infection might provoke a T-cellmediated autoimmune response; such would be the case if the viral proteins shared a crossreacting antigenic determinant with host cell membranes or if a virus infection unmasked or VOL. 13, 1976 altered normal cell constituents causing them to be recognized as foreign. Which, if any, of these mechanisms actually leads to the development of the histopathological lesions after parainfluenza type 1 infection of experimental animals (13, 15, 23, 31 , and our present study) and whether a similar mechanism is involved in chronic parainfluenza type 1 infections in man will require additional studies.
